Livtencity (maribavir)

pCPA File Number: 22070
Negotiation Status:
Under consideration for negotiation
Indication(s):
post-transplant cytomegalovirus (CMV) infection/disease
Sponsor/Manufacturer:
Takeda Canada Inc.
CADTH Project Number:
SR0720
pCPA Engagement Letter Issued:
Not Applicable
Negotiation Process Concluded:
Not Applicable